News About: Pharm. Industry
Concerns growing over multinationals' movement
A series of withdrawals by foreign drug manufacturers from the Korea Pharmaceutical Manufacturers Association has sparked concerns over the possible showdown between domestic and foreign drug makers.
It is unclear ...
Ildong launches Medifoam Silver, antimicrobial silver wound dressingsIldong Pharm says it has launched its new antimicrobial silver wound dressings that combines sustained release antimicrobial silver with highly effective moisture management mat...
|
NSAID patch, Diclo, launched in KoreaChong Kun Dang Pharmaceuticals has launched Diclo, a transdermal patch containing diclofenac diethylammonium, a non-steroidal anti-inflammatory drug for the treatment of musculo...
|
Korea, EU agree on intellectual property rights of pharmaceuticals
Korea and the European Union (EU) reached a tentative agreement on intellectual property rights at the sixth round of their talks at the Shilla hotel in Seoul.
In pharmaceutical patents, Korea and the EU also agree...
KPMA to promote financial support system by third party
The Korea Pharmaceutical Manufacturer Association says it will strengthen its financial support system by third party to root out illicit practices, citing some common types of unfair practices such as price fixing, i...
US FDA approves Hanmi's ceftriaxone injection
Hanmi Fine Chemical says it has received approval from the U.S. Food and Drug Administration for ceftriaxone sodium injection, a third cephalosporin antibiotic.
With the approval of ceftriaxone injection, the compa...
KFDA to toughen ADR reporting system
The government has unveiled its plan to step up its efforts to intensively monitor the adverse events of drugs for people's health, according to the Korea Food and Drug Administration.
Under the plan, the governmen...
Korean scientists map hemophilia-causing protein
Korean scientists say that they have succeeded in constructing a three-dimensional map of a protein linked to hemophilia-A in collaboration with the U.S.-based Fred Hutchinson Cancer Research Center, opening new horiz...
Seoul National Univ. moving to set up financial holding firm
Seoul National University is considering setting up a financial holding company with a paid-in capital of 100 billion won.
Under the plan, the university will establish several affiliated companies involving pharma...
Cho Chang-soo to head Dongwha Pharm
Dongwha Pharm is undergoing a major restructuring in management aimed at enhancing efficiency and the transparency of its operations.
Dongwha Pharm says it has appointed Cho Chang-soo as new president, while the fo...
